MRNA vs TMP · rev $1.94B vs P/E 7.5, rev $79.3M
Moderna Inc (MRNA) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
MRNA currently screens at market cap $24.52B. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the MRNA and TMP stock pages for the full models.
Not investment advice.